States and tribal wildlife agencies, which have struggled to contain the spread of chronic wasting disease, could then apply for funding for mitigation strategies such as testing.
Listing of Federal, National, State, and Provincial agencies' CWD programs and information.
A listing of web-based resources and organizations that provide useful information on CWD.
Receive CWD updates in your inbox
Conversations with experts representing hunter groups, prion biology, diagnostics and epidemiology, wildlife management and health, and human health.
We provide a roundup of the top news, research, and events related to CWD.
The CIDRAP CWD Resource Center hosted a webinar with Sylvie Benestad, PhD, and Jørn Våge, DVM, PhD to discuss CWD in Norway.
Stay in touch with CIDRAP CWD via Twitter for the latest news and research.
Seven COVID-19 symptoms can maximize detection of COVID-19 in the community, according to a large study published in PLOS Medicine yesterday that looked at data from England's REal-time Assessment of Community Transmission-1 (REACT-1) study.
A review and meta-analysis of point-prevalence surveys conducted in Asia over the past two decades found concerning levels of resistance to first-line and last-resort antibiotics in foodborne pathogens isolated from aquatic animals, researchers reported late last week in Nature Communications.
US counties with more excess deaths not attributed to COVID-19 had less health insurance coverage and primary care as well as more at-home deaths, according to a research letter today in JAMA Network Open.
The researchers looked at 2020 data from the US National Center for Health Statistics for 2,096 counties with 319.1 million residents and divided county characteristics into quartiles.
A survey across 73 countries assessing the impact of COVID-19 on the prevention and control of antimicrobial resistance (AMR) highlights reduced availability of nursing, medical, and public health staff for AMR efforts. The study was published today in the Journal of Antimicrobial Chemotherapy.
The rheumatoid arthritis drug baricitinib was shown to reduce mortality in hospitalized COVID-19 patients, according to a randomized, controlled trial published in The Lancet Respiratory Medicine yesterday. Baricitinib acts as a Janus kinases inhibitor and is under emergency use authorization to treat severe COVID-19 by the US Food and Drug Administration.
High-risk adults with mild to moderate COVID-19 who receive a dose of casirivimab and imdevimab have lower hospitalization rates than those who don't, according to a randomized, controlled trial today in The Lancet's EClinicalMedicine. The casirivimab and imdevimab combination is under emergency use authorization by the US Food and Drug Administration.
Out of 574 multiple-occupancy dorm rooms, roommate transmissions occurred only 20% of the time, according to a study during the fall 2020 semester at the University of Colorado Boulder.
Chronic wasting disease (CWD) has been detected in an adult deer found dead in early May in the Wisconsin city of Brooklyn, marking the state's first such case in Green Lake County, the Wisconsin Department of Natural Resources (WDNR) said late last week.
COVID-19 infection was 94% less likely in people previously infected than in those never infected, according to a research letter late last week in JAMA Internal Medicine. However, the researchers note, their study concluded before COVID-19 variants became dominant.
The Global Antibiotic Research and Development Partnership (GARDP), on behalf of the Drugs for Neglected Diseases initiative, issued a statement this week that called on World Health Organization (WHO) member states to strengthen their responses to antimicrobial resistance (AMR).